PRCT logo

PROCEPT BIOROBOTICS CORP

PRCTNASDAQ
🏆 #2284 by market capEarnings Nov 4 · PostUS Equity
——
Quote unavailable
🔔
Track PRCT
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1.16B
Small Cap
📈Revenue Growth (YoY)
22.7%
Healthy
📊Gross Margin
64.2%
High
💵FCF Margin
—
⚖️P/S Ratio
3.4x
Fair
Otter Score
72
Strong
No chart data available for PRCT.

Trading Snapshot

Day Range
—
52-Week Range
$16.67 – $38.11
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
57.3M
Next Earnings
2026-11-04

Fundamentals Snapshot

Annual Revenue
$308M
Last Q Revenue
$94M
P/E Ratio
—
P/S Ratio
3.4x
EPS (TTM)
$-1.95
Dividend Yield
—
Dilution (1yr)
+4.1%
PRCT logo

PROCEPT BIOROBOTICS CORP

PRCT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$308M▲ +37.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
63.7%▲ +4.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$104M▲ +7.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$58M▼ −43.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
56.1M▲ +4.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$208M▼ −$45M YoY
StockOtter · stockotter.space

About PROCEPT BIOROBOTICS CORP

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
72/100
Analyst data unavailable.

Latest News & Updates

News unavailable.